Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
As of close of business last night, Health Catalyst Inc’s stock clocked out at $4.14, down -6.97% from its previous closing price of $4.45. In other words, the price has decreased by -$6.97 from its previous closing price. On the day, 0.53 million shares were traded. HCAT stock price reached its highest trading level at $4.255 during the session, while it also had its lowest trading level at $4.0599.
Ratios:
To gain a deeper understanding of HCAT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.42 and its Current Ratio is at 1.42. In the meantime, Its Debt-to-Equity ratio is 1.10 whereas as Long-Term Debt/Eq ratio is at 0.46.
Evercore ISI Upgraded its In-line to Outperform on January 03, 2024, while the target price for the stock was maintained at $11.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 03 ’25 when DANIEL LESUEUR bought 10,418 shares for $4.45 per share.
Landry Benjamin sold 13,827 shares of HCAT for $62,860 on Mar 06 ’25. The General Counsel now owns 160,437 shares after completing the transaction at $4.55 per share. On Mar 05 ’25, another insider, LeSueur Daniel, who serves as the Chief Operating Officer of the company, sold 16,902 shares for $4.52 each. As a result, the insider received 76,331 and left with 216,250 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HCAT now has a Market Capitalization of 290671872 and an Enterprise Value of 300937088. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.95 while its Price-to-Book (P/B) ratio in mrq is 0.73. Its current Enterprise Value per Revenue stands at 0.982 whereas that against EBITDA is -11.864.
Stock Price History:
The Beta on a monthly basis for HCAT is 1.55, which has changed by -0.37082064 over the last 52 weeks, in comparison to a change of 0.036926866 over the same period for the S&P500. Over the past 52 weeks, HCAT has reached a high of $9.24, while it has fallen to a 52-week low of $3.76. The 50-Day Moving Average of the stock is -16.06%, while the 200-Day Moving Average is calculated to be -39.04%.
Shares Statistics:
It appears that HCAT traded 837.68K shares on average per day over the past three months and 635370 shares per day over the past ten days. A total of 70.21M shares are outstanding, with a floating share count of 66.95M. Insiders hold about 4.65% of the company’s shares, while institutions hold 77.19% stake in the company. Shares short for HCAT as of 1741910400 were 2938917 with a Short Ratio of 3.51, compared to 1739491200 on 2063283. Therefore, it implies a Short% of Shares Outstanding of 2938917 and a Short% of Float of 4.2600001999999995.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
